On the other hand, the OR of ILD incidence at grade ≥ 3 with VEGF/VEGFR inhibitors was 0.87 (95% CI, 0.51–1.48; p = 0.60), which did not indicate a significant incidence. This evidence concerns the gene VEGFA and interstitial lung disease.